{"url_path":"/fda/drug/recalls/D-0724-2026","section_key":"summary","section_title":"DRUG Recall: Rising Pharma Holding, Inc. — Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-07-13","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0724-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Rising Pharma Holding, Inc."},"word_count":97,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0724-2026\n\n**Recalling firm:** Rising Pharma Holding, Inc.\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-07-13\n**Report date:** 2026-07-29\n\n## Product\nRising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.\n\n## Reason\nPresence of Precipitate: medication was crystallizing and particles floating in the bottle\n\n## Affected lots\nLots: Batch # CR2518, Exp. 11/2027; Batch # CR2601, Exp. 12/2027; CR2602, CR2603, Exp. 01/2028; CR2604, CR2605, Exp. 02/2028.\n\n## Distribution\nNationwide U.S.A."}